Preclinical mouse models for studying cholangiocarcinoma.

Area of Science:

• Hepatobiliary cancers
• Oncology
• Translational research

Background:

• Cholangiocarcinoma (CCA) is a challenging liver and bile duct cancer with limited treatment options.
• Developing effective therapies requires robust animal models for research.
• Understanding CCA pathogenesis is key to improving patient outcomes.

Purpose of the Study:

• To provide a comprehensive review of existing cholangiocarcinoma (CCA) mouse models.
• To analyze the advantages and limitations of different modeling strategies.
• To guide future research in optimizing CCA models.

Main Methods:

• Review of chemical induction models (e.g., DEN, AOM).
• Analysis of genetically engineered models targeting key genes (e.g., KRAS, TP53, IDH).
• Evaluation of xenograft models, including patient-derived xenografts (PDXs).

Main Results:

• Chemical models offer insights into early tumorigenesis.
• Genetic models elucidate molecular mechanisms of CCA.
• Xenografts facilitate preclinical therapeutic evaluation.
• Each model type presents unique strengths and weaknesses for CCA research.

Conclusions:

• Diverse CCA mouse models are available, each with specific applications.
• Selecting the appropriate model is critical for advancing CCA research.
• Further innovation in CCA modeling is needed for improved therapeutic development.